Læknaneminn - 01.04.1986, Síða 79

6. Leeson, R.C. Leeson, T.S. Histo-
logy, Third edition, W.B. Saunders
Company, Philadclphia, 1976.
7. Tseta, N.G. Alien, T.D. Lajtha,
L.G. Onions. D. Jarret, O. Generat-
ion of osteodasts in vitro. J. Cell
Sci.,1981,47, 127-137.
8. Bonucci, E. New knowledge on the
origin, function and fate of osteocl-
asts. Clin. Orthop. Rel. Res., 1981,
jul-aug.
9. Chambers, T.J. The cellular basis of
bone resorption Clin. Orthop. Rel.
Res., 1981, 151.
10. Jensson, Ó. Árnason, A. Skaftadóttir,
I. Linnet, H. Jónmundsson, G. K.
Snorradóttir, M. Arfgeng marmara-
beinveiki (osteopetrosis) í ungbörn-
um. Læknabl., 1983,69,35-41.
11. Tinkler, S.M.B. Williams, J.b.
Linder, J.E. Johnson, N.W. Kinetics
of osteoclast formation: the si gnific-
ance of blood monocytes as osteocl-
ast precursors during 1-
hydroxycholecalciferol-stimulated
bonc resorption in the mouse. J.
Anat., 1983, 137, 2, 335-340.
12. Marks, S.C. Schneider, G.B. Evi-
dence for a relationship between
lymphoid cells and osteoclasts: Bone
resorption restored in ia (osteopetrot-
ic) rats by lymphocytes, monocytes
and macrophages from a norntal litt-
ermate. Am. J. Anat., 1978, 152,
331-342.
13. Loutit. J.F. Nisbet, N.W. Resorption
ofbone. Lancet, jul 7, 1979.
14. Ash, P. Loutit, J.F. Townsend,
K.M.S. Osteoclasts derived from
haematopoietic stem cells. Nature,
1980, 283, feb 14.
15. Marks, S.C. Walker, D.G. The
hematogenous origin of osteoclasts:
experimental evidence from osteop-
etrotic (micropthalamic) mice treated
with spleen cells from beige mouse
donors. Am. J. Anat., 1981, 161,1-
10
16. Miller, S.C. Marks, S.C.jr. Osteo-
clast kinetics in osteopetrotic (ia) rats
cured by spleen cell transfers front
normal littermates. Calcif. Tissue
Int., 1982, 34, 422-437.
17. Coccia, P.F. Krivit, W. Cervenka, J.
Clawson, C. Kersey, J.H. Kim, T.H.
et al. Successful bone-marrow trans-
plantation for infantile malignant
osteopetrosis. N. Engl. J. Med. ,
1980, 302, 13, mar 27.
18. Tinkler, S.M.B. Linder, J.E. Willi-
ams, D.M. Johnson, N.W. Format-
ion of osteoclasts from blood mono-
cytes during vit D-stimulated bone
resorption in mice. J. Anat., 1981,
133, 3, 389-396.
19. Zallone, A.Z Teti, A. Primavera,
M. V. Resorption of vital or devitaliz-
ed bone by isolated osteoclasts in
vitro. Cell Tissue Res., 1984, 235,
561-564
20. Horton, M.A. Rimnter, E.F Lewis,
D. Pringle, J.A.S. Fuller, K.
Chambers. T.J. Cell surface charact-
eristization of the human osteoclast:
phenotypic relationship to other bone
marrow-derived cell types. J. Pathol.,
1984, 144, 281-294.
21. Chantbers, T.J. Horton, M.A. Ost-
eoclasts: Putative, surrogative and
authentic. J. PathoL, 1984, 144 :295-
296.
22. Braidman, I.P. Andreson, D.C.
Vitamin D and the lympomedullary
system. Lancet, 1984 , june 23.
23. Committee on Human Leukocyte
Differentiation Antigens: IUIS-WHO
Nomenclature Subcommittee. Pro-
posed nomenclature for human leuk-
ocyte differentiation antigens: a corr-
ection. Immunol. Today, 1984, 5,
10.
24. Chambers, T.J. Fuller, K.
McSheehy, P.M.J. Pringle, J.A.S.
The effects of calcium regulating
hormones on bone resorption by
isolated human osteoclastoma cells.
J. Pathol., 1985, 145, 297-305.
25. Underwood, J.C.E. From where
comes the osteoclast. J. Pathol.,
1984, 144, 225-226.
26. Galasko, C.S.B. Bennett, A. Rclat-
ionship of bone destruction in skeletal
metastases to osteoclast activation
and prostaglandins. Nature, 1976,
63, oct 7.
27. Schelling. S.H. Wolfe, H.J. Tashji-
an. A.H.jr. Role of the osteoclast in
prostaglandin E2-stimulated bone res-
orption. A correlative morphometric
and biochentical analysis. Lab.
Invest., 1980, 42. 3.
28. Galasko, C.S.B Rawlins, B.
Bennett, A. Tinting of indomethacine
in the control of prostaglandins, ost-
eoclasts and bone destruction produc-
ed by VX2 carcinoma in rabbits Br.
J. Canc., 1979, 40,360.
29. Robinson, D.R. Tashjian, A.H. Le-
vine, L. Prostaglandin-stimulated
bone resorption by rheumatoid syn-
ovia. A possible mechanisnt for bone
destruction in rheumatoid arthritis. J.
Clin. Invest., 1975, 56, 1181-1188.
30. Chambers, T.J. Dunn, C.J. Thc
effect of Parathyroid hormone, 1,25-
dihydroxycholecalciferol and pros-
taglandins on the cytoplasmic activity
of osteoclasts. J. Pathol. 137, 1982,
193-203.
31. Ransjö, M. Fredholnt, B.B. Lerner.
U. Gustafson, G.T. Differences in
basal and stimulated cyclic AMP
content in calvaria bones from normal
mice and mice with an impaired lys-
osontal function (Beige Mice). Euro.
J. Clin. Invest., 1985. 15, 15-19.
32. Ali. N.N. Auger, D.W. Bennett, A.
Edwards, D.A. Harris, M. Effect of
prostacyclin and its breakdown pro-
duct 6-oxo-PGF1 on bone resorption
in vitro. Prostacyclin, ed. Vane.J.R.
Bergström.S.
33. Hough, A.jr Seyberth, H. Oates, J.
Hartmann, W. Changes in bone and
bone marrow of rabbits bearing the
VX-2 carcinoma. A comparison of
local and distant effects. Am. J.
Pathol. 87, 3.
34. Galasko. C.S.B. Mechanisms of
bone destruction in the development
of skeletal metastases. Nature, 1976,
263.
35. Soskolne, W.A. The osteoclast-
endothelium interface during bone
resorption in the femurs of young
rabbits. Calcif. Tissue Res., 1976,
203,487-492.
36. Rutherford, B. Trummel, C.L. Mon-
ocyte-mediated bone resorption
involves release of nondialyzable
substances in addition to prostagland-
in. J. Reticulo Endothel. Soc.
(RES)., 1983, 33, 175-184.
LÆKNANEMINN Vm5- Vm6 - 38.-39. árg.
77